1-(4-fluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 2g

3-Bromo-4-morpholinobenzoic acid, 95.0%, 25g

5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoic acid, 97%, 250mg

2-Fluoro-4-pyridinecarboxylic acid, 97.0%, 5g

7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one, 95.0%, 250mg

2-Ethynylpyridine>97.0%(GC)1mL

(R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one, 95.0%, 250mg

BLONANSERIN, 95%, 250mg

MES, 1 kg

1-Methoxy-2-methylbut-3-yn-2-ol, 95%, 500mg

4,4,5,5-Tetramethyl-2-(3,3,5,5-tetramethyl-1-cyclohexen-1-yl)-1,3,2-dioxaborolane, 95.0%, 1g

H-Asp(OtBu)-OMe.HCl, 95.0%, 100g

6'-(Diethylamino)-2'-((2,4-dimethylphenyl)amino)-3'-methyl-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one, 98%, 5g